• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样β蛋白与线粒体的相互作用。

Amyloid-Beta interaction with mitochondria.

作者信息

Pagani Lucia, Eckert Anne

机构信息

Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Clinics, University of Basel, Wilhelm Klein-Straße 27, 4012 Basel, Switzerland.

出版信息

Int J Alzheimers Dis. 2011 Mar 15;2011:925050. doi: 10.4061/2011/925050.

DOI:10.4061/2011/925050
PMID:21461357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3065051/
Abstract

Mitochondrial dysfunction is a hallmark of amyloid-beta(Aβ)-induced neuronal toxicity in Alzheimer's disease (AD). The recent emphasis on the intracellular biology of Aβ and its precursor protein (AβPP) has led researchers to consider the possibility that mitochondria-associated and/or intramitochondrial Aβ may directly cause neurotoxicity. In this paper, we will outline current knowledge of the intracellular localization of both Aβ and AβPP addressing the question of how Aβ can access mitochondria. Moreover, we summarize evidence from AD postmortem brain as well as cellular and animal AD models showing that Aβ triggers mitochondrial dysfunction through a number of pathways such as impairment of oxidative phosphorylation, elevation of reactive oxygen species (ROS) production, alteration of mitochondrial dynamics, and interaction with mitochondrial proteins. In particular, we focus on Aβ interaction with different mitochondrial targets including the outer mitochondrial membrane, intermembrane space, inner mitochondrial membrane, and the matrix. Thus, this paper establishes a modified model of the Alzheimer cascade mitochondrial hypothesis.

摘要

线粒体功能障碍是阿尔茨海默病(AD)中淀粉样β蛋白(Aβ)诱导的神经元毒性的一个标志。最近对Aβ及其前体蛋白(AβPP)细胞内生物学的重视,促使研究人员考虑线粒体相关和/或线粒体内Aβ可能直接导致神经毒性的可能性。在本文中,我们将概述目前关于Aβ和AβPP细胞内定位的知识,探讨Aβ如何进入线粒体的问题。此外,我们总结了来自AD死后大脑以及细胞和动物AD模型的证据,表明Aβ通过多种途径触发线粒体功能障碍,如氧化磷酸化受损、活性氧(ROS)生成增加、线粒体动力学改变以及与线粒体蛋白相互作用。特别是,我们关注Aβ与不同线粒体靶点的相互作用,包括线粒体外膜、膜间隙、线粒体内膜和线粒体基质。因此,本文建立了阿尔茨海默病级联线粒体假说的修正模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/de88a7a5c814/IJAD2011-925050.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/101051398fce/IJAD2011-925050.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/16ac99716292/IJAD2011-925050.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/de88a7a5c814/IJAD2011-925050.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/101051398fce/IJAD2011-925050.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/16ac99716292/IJAD2011-925050.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8518/3065051/de88a7a5c814/IJAD2011-925050.003.jpg

相似文献

1
Amyloid-Beta interaction with mitochondria.淀粉样β蛋白与线粒体的相互作用。
Int J Alzheimers Dis. 2011 Mar 15;2011:925050. doi: 10.4061/2011/925050.
2
New insights in the amyloid-Beta interaction with mitochondria.淀粉样β蛋白与线粒体相互作用的新见解。
J Aging Res. 2012;2012:324968. doi: 10.1155/2012/324968. Epub 2012 Mar 19.
3
Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.线粒体淀粉样β水平与不同脑区线粒体功能障碍的程度以及阿尔茨海默病转基因小鼠认知障碍的严重程度相关。
J Alzheimers Dis. 2010;20 Suppl 2:S535-50. doi: 10.3233/JAD-2010-100342.
4
Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity.线粒体功能障碍——阿尔茨海默病的终结之始?tau 蛋白和淀粉样β毒性的独立和协同模式。
Alzheimers Res Ther. 2011 May 5;3(2):15. doi: 10.1186/alzrt74.
5
Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.阿尔茨海默病中β-淀粉样蛋白的前体非依赖性过量产生:线粒体功能障碍作为不对称RNA依赖性β-淀粉样前体蛋白(βAPP)mRNA扩增的可能引发因素。一种驱动阿尔茨海默病的机制
Ann Integr Mol Med. 2019;1(1):61-74. Epub 2019 Nov 20.
6
Role of mitochondrial amyloid-beta in Alzheimer's disease.线粒体淀粉样β在阿尔茨海默病中的作用。
J Alzheimers Dis. 2010;20 Suppl 2:S569-78. doi: 10.3233/JAD-2010-100357.
7
Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.抑制淀粉样蛋白-β(Abeta)肽结合型醇脱氢酶- Abeta 相互作用可减少阿尔茨海默病小鼠模型中的 Abeta 积累并改善线粒体功能。
J Neurosci. 2011 Feb 9;31(6):2313-20. doi: 10.1523/JNEUROSCI.4717-10.2011.
8
Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.线粒体功能障碍的研究进展:衰老、淀粉样β蛋白和 tau-A 这一有害三联体。
Antioxid Redox Signal. 2012 Jun 15;16(12):1456-66. doi: 10.1089/ars.2011.4400. Epub 2012 Jan 30.
9
Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.阿尔茨海默病 APP/PS1 小鼠模型中线粒体相关膜蛋白的早期无症状变化。
Mol Neurobiol. 2018 Oct;55(10):7839-7857. doi: 10.1007/s12035-018-0955-6. Epub 2018 Feb 22.
10
Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.抑制动力相关蛋白1可改善阿尔茨海默病模型中的突触抑制、β淀粉样蛋白沉积和认知障碍。
J Neurosci. 2017 May 17;37(20):5099-5110. doi: 10.1523/JNEUROSCI.2385-16.2017. Epub 2017 Apr 21.

引用本文的文献

1
Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor Immunity.阿尔茨海默病相关淀粉样前体蛋白可预防衰老应激诱导的线粒体自噬和富马酸耗竭,从而改善抗肿瘤免疫。
Cancer Res. 2025 Aug 7. doi: 10.1158/0008-5472.CAN-24-4740.
2
Estradiol Prevents Amyloid Beta-Induced Mitochondrial Dysfunction and Neurotoxicity in Alzheimer's Disease via AMPK-Dependent Suppression of NF-κB Signaling.雌二醇通过AMPK依赖的NF-κB信号抑制预防阿尔茨海默病中β-淀粉样蛋白诱导的线粒体功能障碍和神经毒性。
Int J Mol Sci. 2025 Jun 27;26(13):6203. doi: 10.3390/ijms26136203.
3

本文引用的文献

1
Is mPTP the gatekeeper for necrosis, apoptosis, or both?线粒体通透性转换孔(mPTP)是坏死、凋亡还是两者的守门人?
Biochim Biophys Acta. 2011 Apr;1813(4):616-22. doi: 10.1016/j.bbamcr.2010.09.013. Epub 2010 Oct 1.
2
Mitochondrial γ-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein.线粒体 γ-分泌酶参与线粒体相关淀粉样前体蛋白的代谢。
FASEB J. 2011 Jan;25(1):78-88. doi: 10.1096/fj.10-157230. Epub 2010 Sep 10.
3
Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure.
Volatile oil of : potential candidate drugs for mitigating dementia.
挥发油:缓解痴呆症的潜在候选药物。
Front Pharmacol. 2025 Apr 23;16:1552801. doi: 10.3389/fphar.2025.1552801. eCollection 2025.
4
Systematic Identification of Mitochondrial Signatures in Alzheimer's Disease and Inflammatory Bowel Disease.阿尔茨海默病和炎症性肠病中线粒体特征的系统鉴定
Mol Neurobiol. 2025 Mar 14. doi: 10.1007/s12035-025-04826-4.
5
Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer's Disease: An In Vitro Study.研究高粱对阿尔茨海默病中tau蛋白磷酸化和线粒体功能障碍调节的影响:一项体外研究
Nutrients. 2025 Jan 30;17(3):516. doi: 10.3390/nu17030516.
6
MAD-microbial (origin of) Alzheimer's disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems.MAD-微生物(起源的)阿尔茨海默病假说:从感染和抗菌反应到关键铜基系统的破坏
Front Neurosci. 2024 Oct 2;18:1467333. doi: 10.3389/fnins.2024.1467333. eCollection 2024.
7
Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders.解析大麻及大麻素在神经系统疾病中的治疗潜力
Curr Pharm Des. 2025;31(8):630-644. doi: 10.2174/0113816128318194240918113954.
8
Unraveling the nexus of age, epilepsy, and mitochondria: exploring the dynamics of cellular energy and excitability.解析年龄、癫痫与线粒体之间的关系:探索细胞能量与兴奋性的动态变化。
Front Pharmacol. 2024 Sep 5;15:1469053. doi: 10.3389/fphar.2024.1469053. eCollection 2024.
9
The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease.成年海马神经发生与阿尔茨海默病认知障碍的关系。
Alzheimers Dement. 2024 Oct;20(10):7369-7383. doi: 10.1002/alz.14179. Epub 2024 Aug 21.
10
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.神经毒性β-淀粉样寡聚体导致线粒体功能障碍——神经元中PANoptosis的触发因素。
Front Aging Neurosci. 2024 May 14;16:1400544. doi: 10.3389/fnagi.2024.1400544. eCollection 2024.
银杏叶提取物可改善氧化磷酸化性能并挽救 abeta 诱导的衰竭。
PLoS One. 2010 Aug 24;5(8):e12359. doi: 10.1371/journal.pone.0012359.
4
Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects.线粒体功能障碍:脑衰老和阿尔茨海默病的共同最后通路——治疗方面。
Mol Neurobiol. 2010 Jun;41(2-3):159-71. doi: 10.1007/s12035-010-8141-5. Epub 2010 May 12.
5
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.体内淀粉样-β和tau 病理在粒体上的汇聚。
Mol Neurobiol. 2010 Jun;41(2-3):107-14. doi: 10.1007/s12035-010-8109-5. Epub 2010 Mar 9.
6
Alzheimer's disease.阿尔茨海默病
N Engl J Med. 2010 Jan 28;362(4):329-44. doi: 10.1056/NEJMra0909142.
7
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?异常的线粒体动力学——阿尔茨海默病的新治疗靶点?
Mol Neurobiol. 2010 Jun;41(2-3):87-96. doi: 10.1007/s12035-009-8095-7. Epub 2010 Jan 27.
8
Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.淀粉样蛋白-β和tau 协同损害三转基因阿尔茨海默病小鼠的氧化磷酸化系统。
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20057-62. doi: 10.1073/pnas.0905529106. Epub 2009 Nov 6.
9
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.线粒体功能障碍是阿尔茨海默病病理生理学的一个触发因素。
Biochim Biophys Acta. 2010 Jan;1802(1):2-10. doi: 10.1016/j.bbadis.2009.10.006. Epub 2009 Oct 21.
10
Mitochondria and Alzheimer's disease: amyloid-beta peptide uptake and degradation by the presequence protease, hPreP.线粒体与阿尔茨海默病:前导肽蛋白酶 hPreP 对淀粉样β肽的摄取和降解。
J Bioenerg Biomembr. 2009 Oct;41(5):447-51. doi: 10.1007/s10863-009-9244-4.